These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31632397)

  • 1. Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.
    Tatapudi VS; Montgomery RA
    Front Immunol; 2019; 10():2306. PubMed ID: 31632397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifaceted role of complement in kidney transplantation.
    Biglarnia AR; Huber-Lang M; Mohlin C; Ekdahl KN; Nilsson B
    Nat Rev Nephrol; 2018 Dec; 14(12):767-781. PubMed ID: 30367174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement in renal transplantation: The road to translation.
    Jager NM; Poppelaars F; Daha MR; Seelen MA
    Mol Immunol; 2017 Sep; 89():22-35. PubMed ID: 28558950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of complement in antibody mediated transplant rejection.
    Thurman JM; Panzer SE; Le Quintrec M
    Mol Immunol; 2019 Aug; 112():240-246. PubMed ID: 31195225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement system in lung transplantation.
    Ali HA; Pavlisko EN; Snyder LD; Frank M; Palmer SM
    Clin Transplant; 2018 Apr; 32(4):e13208. PubMed ID: 29374425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in antibody-mediated rejection in kidney transplantation.
    Stegall MD; Chedid MF; Cornell LD
    Nat Rev Nephrol; 2012 Nov; 8(11):670-8. PubMed ID: 23026942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Complement Dependent Assays in Kidney Transplantation.
    Lan JH; Tinckam K
    Transplantation; 2018 Jan; 102(1S Suppl 1):S14-S22. PubMed ID: 29266058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in organ transplantation.
    Asgari E; Zhou W; Sacks S
    Curr Opin Organ Transplant; 2010 Aug; 15(4):486-91. PubMed ID: 20631616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement modulation in solid-organ transplantation.
    Touzot M; Obada EN; Beaudreuil S; François H; Durrbach A
    Transplant Rev (Orlando); 2014 Jul; 28(3):119-25. PubMed ID: 24996770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of innate immunological mechanisms as a route to drug minimization.
    Asgari E; Farrar CA; Sacks SH
    Curr Opin Organ Transplant; 2014 Aug; 19(4):342-7. PubMed ID: 24905023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.
    Viglietti D; Lefaucheur C; Glotz D
    Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in kidney transplantation: from risk stratification to therapeutic strategies.
    Lefaucheur C
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):57-8. PubMed ID: 25546762
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective.
    Biglarnia AR; Ekdahl KN; Nilsson B
    Adv Exp Med Biol; 2015; 865():211-33. PubMed ID: 26306452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
    Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Complement in Organ Transplantation.
    Grafals M; Thurman JM
    Front Immunol; 2019; 10():2380. PubMed ID: 31636644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response and histology of humoral rejection in kidney transplantation.
    González-Molina M; Ruiz-Esteban P; Caballero A; Burgos D; Cabello M; Leon M; Fuentes L; Hernandez D
    Nefrologia; 2016; 36(4):354-67. PubMed ID: 27267916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
    PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.